Philippe Clevenbergh

Summary

Publications

  1. ncbi request reprint Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients
    P Clevenbergh
    Department of Infectious Diseases, Nice University Hospital, France
    HIV Clin Trials 3:36-44. 2002
  2. ncbi request reprint Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients
    P Clevenbergh
    Centre Hospitalier Universitaire Lariboisière, Paris, France
    HIV Med 5:284-8. 2004
  3. ncbi request reprint Impact of various antiretroviral drugs and their plasma concentrations on plasma lipids in heavily pretreated HIV-infected patients
    P Clevenbergh
    Department of Infectious Diseases, CHU Bichat, Paris, France
    HIV Clin Trials 4:330-6. 2003
  4. ncbi request reprint Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trial
    P Clevenbergh
    Centre Hospitalier Universitaire, Nice, France
    HIV Clin Trials 4:84-91. 2003
  5. ncbi request reprint Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1
    Philippe Clevenbergh
    Outpatients Clinic, Paris, France
    Antivir Ther 7:305-8. 2002
  6. ncbi request reprint PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results
    Philippe Clevenbergh
    Infectious Diseases Department, CHU Nice, Nice, France
    AIDS 16:2311-5. 2002
  7. ncbi request reprint Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient
    P Clevenbergh
    Department of Infectious Diseases, Nice University Hospital, L Archet, France
    Scand J Infect Dis 34:546-7. 2002
  8. ncbi request reprint Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen
    P Clevenbergh
    Department of Infectious Diseases, Nice University Hospital, France
    J Infect 44:194-5. 2002
  9. ncbi request reprint Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in Africa
    P Clevenbergh
    PharmAccess Foundation, Amsterdam, The Netherlands
    HIV Clin Trials 7:255-62. 2006
  10. ncbi request reprint Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view
    Philippe Clevenbergh
    Infectious Diseases and Internal Medicine Department, Hopital Lariboisiere, Paris, France
    Curr HIV Res 2:309-21. 2004

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients
    P Clevenbergh
    Department of Infectious Diseases, Nice University Hospital, France
    HIV Clin Trials 3:36-44. 2002
    ..On the contrary, hypersusceptibility to NNRTIs in patients having failed nucleoside reverse transcriptase inhibitor (NRTI)-containing regimens has been described and has been associated with improved outcome...
  2. ncbi request reprint Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients
    P Clevenbergh
    Centre Hospitalier Universitaire Lariboisière, Paris, France
    HIV Med 5:284-8. 2004
    ..We assessed the predictive factors associated with virological success of APV/RTV-based regimens...
  3. ncbi request reprint Impact of various antiretroviral drugs and their plasma concentrations on plasma lipids in heavily pretreated HIV-infected patients
    P Clevenbergh
    Department of Infectious Diseases, CHU Bichat, Paris, France
    HIV Clin Trials 4:330-6. 2003
    ..To evaluate the frequency and the magnitude of lipid abnormalities (LA) in respect to the nature of the antiretroviral drug and its plasma concentrations...
  4. ncbi request reprint Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trial
    P Clevenbergh
    Centre Hospitalier Universitaire, Nice, France
    HIV Clin Trials 4:84-91. 2003
    ....
  5. ncbi request reprint Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1
    Philippe Clevenbergh
    Outpatients Clinic, Paris, France
    Antivir Ther 7:305-8. 2002
    ..New and more effective drugs are needed for patients with HIV-1 that is resistant to more than one of the current three classes of HIV drugs...
  6. ncbi request reprint PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results
    Philippe Clevenbergh
    Infectious Diseases Department, CHU Nice, Nice, France
    AIDS 16:2311-5. 2002
    ..A randomized study to evaluate the usefulness of protease inhibitor (PI) therapeutic drug monitoring (TDM) in antiretroviral-experienced HIV-infected patients...
  7. ncbi request reprint Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient
    P Clevenbergh
    Department of Infectious Diseases, Nice University Hospital, L Archet, France
    Scand J Infect Dis 34:546-7. 2002
    ..However, L. infantum can be considered a cause of renal failure in HIV-infected patients...
  8. ncbi request reprint Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen
    P Clevenbergh
    Department of Infectious Diseases, Nice University Hospital, France
    J Infect 44:194-5. 2002
    ..Safety of life-long CYP450 inhibition has still to be demonstrated...
  9. ncbi request reprint Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in Africa
    P Clevenbergh
    PharmAccess Foundation, Amsterdam, The Netherlands
    HIV Clin Trials 7:255-62. 2006
    ..In addition to other forms of training, scheduled teleconferences (TCs) have been organized to support a comprehensive HIV treatment program delivered by a private company's health team...
  10. ncbi request reprint Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view
    Philippe Clevenbergh
    Infectious Diseases and Internal Medicine Department, Hopital Lariboisiere, Paris, France
    Curr HIV Res 2:309-21. 2004
    ..We also highlight the benefits and limits of this tool as an adjunct in the care of HIV-infected patients...
  11. ncbi request reprint Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa
    Pierre Sellier
    Service de Medecine Interne A, Hopital Lariboisiere, Paris, France
    Clin Infect Dis 43:654-7. 2006
    ..This was mainly related to self-perceived insufficient support from family members and/or fear of the consequences of disclosure of their HIV infection status to their family...
  12. ncbi request reprint Fatal interruption of a 3TC-containing regimen in a HIV-infected patient due to re-activation of chronic hepatitis B virus infection
    Pierre Sellier
    , , Paris, France
    Scand J Infect Dis 36:533-5. 2004
  13. doi request reprint Long-term voluntary counseling and testing (VCT) uptake dynamics in a multicountry HIV workplace program in sub-Saharan Africa
    Stefaan F Van der Borght
    Heineken International Health Affairs, 2e Weteringsplantsoen 21, Amsterdam, The Netherlands
    AIDS Care 22:195-205. 2010
    ..Employees' spouses are harder to reach than employees and extra efforts should be undertaken to reach them as well. Uptake of HIV testing can be actively influenced by educational or promotional activities...
  14. ncbi request reprint Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa
    Stefaan F Van der Borght
    Heineken International Health Affairs, Amsterdam, The Netherlands
    Antivir Ther 14:63-74. 2009
    ..This study aimed to evaluate the effectiveness of an HIV workplace programme in sub-Saharan Africa...
  15. doi request reprint Central nervous system tuberculomas in 23 patients
    Horea Man
    Department of Internal Medicine A, Lariboisiere Hospital, Paris, France
    Scand J Infect Dis 42:450-4. 2010
    ..Results did not contradict the use of a 12-month regimen as currently recommended...
  16. ncbi request reprint Skin lightening and its complications among African people living in Paris
    Antoine Petit
    Dermatology Service, Hopital Saint Louis, Paris, France
    J Am Acad Dermatol 55:873-8. 2006
    ..Complications caused by skin lightening practices have not been systematically studied in Europe...
  17. ncbi request reprint Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions
    Philippe Halfon
    Laboratoire Alphabio, Marseilles, Belgium
    AIDS 17:1351-61. 2003
    ..The viral load increase in most patients is compatible with the outgrowth of virus with fewer or no mutations...
  18. ncbi request reprint Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries
    Papa S Sow
    Centre Hospitalier Universitaire de Fann, Dakar, Senegal
    J Acquir Immune Defic Syndr 44:262-7. 2007
    ..HIV-1 screening, therapy, counseling, monitoring, training, and education were provided free of charge...
  19. ncbi request reprint Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine
    Andrea De Luca
    Institute of Clinical Infectious Diseases, Catholic University, Roma, 00168, Italy
    J Infect Dis 196:1645-53. 2007
    ..Consensus on the interpretation of mutations in the human immunodeficiency virus (HIV)-1 reverse transcriptase (RT) gene that predict the response to didanosine treatment is needed...
  20. ncbi request reprint Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation
    Pierre Marie Roger
    Service des Maladies Infectieuses et Tropicales, hôpital de l Archet 1, Centre Hospitalo Universitaire de Nice BP3079, 06202, Nice Cedex 3, France
    J Infect Dis 185:463-70. 2002
    ..Down-regulation of CD4(+) T cell apoptosis by antiretroviral treatment is the main mechanism associated with early CD4(+) T cell increase...
  21. ncbi request reprint Delay between first HIV-related symptoms and diagnosis of HIV infection in patients attending the internal medicine department of the Fondation Jeanne Ebori (FJE), Libreville, Gabon
    Madeleine Okome-Nkoumou
    Infectious Diseases Unit, Fondation Jeanne Ebori, Libreville, Gabon
    HIV Clin Trials 6:38-42. 2005
    ..Better communication between allopathic physicians and traditional or faith healers could also improve the care of HIV-infected patients...